vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and AdvanSix Inc. (ASIX). Click either name above to swap in a different company.
American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $359.9M, roughly 1.6× AdvanSix Inc.). American Healthcare REIT, Inc. runs the higher net margin — 1.9% vs -0.8%, a 2.7% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs 9.4%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs 3.4%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
AHR vs ASIX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $359.9M |
| Net Profit | $10.8M | $-2.8M |
| Gross Margin | 14.8% | 7.6% |
| Operating Margin | 19.8% | -0.7% |
| Net Margin | 1.9% | -0.8% |
| Revenue YoY | 13.5% | 9.4% |
| Net Profit YoY | 133.9% | -892.9% |
| EPS (diluted) | $0.07 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | $359.9M | ||
| Q3 25 | $532.1M | $374.5M | ||
| Q2 25 | $501.3M | $410.0M | ||
| Q1 25 | $497.2M | $377.8M | ||
| Q4 24 | $496.8M | $329.1M | ||
| Q3 24 | $476.8M | $398.2M | ||
| Q2 24 | $458.0M | $453.5M | ||
| Q1 24 | $452.1M | $336.8M |
| Q4 25 | $10.8M | $-2.8M | ||
| Q3 25 | $55.9M | $-2.6M | ||
| Q2 25 | $9.9M | $31.4M | ||
| Q1 25 | $-6.8M | $23.3M | ||
| Q4 24 | $-31.8M | $352.0K | ||
| Q3 24 | $-4.1M | $22.3M | ||
| Q2 24 | $2.0M | $38.9M | ||
| Q1 24 | $-3.9M | $-17.4M |
| Q4 25 | 14.8% | 7.6% | ||
| Q3 25 | 14.6% | 6.8% | ||
| Q2 25 | 15.0% | 14.3% | ||
| Q1 25 | 13.0% | 14.2% | ||
| Q4 24 | 13.3% | 3.4% | ||
| Q3 24 | 12.5% | 14.4% | ||
| Q2 24 | 12.1% | 17.9% | ||
| Q1 24 | 10.7% | 0.9% |
| Q4 25 | 19.8% | -0.7% | ||
| Q3 25 | 19.9% | -0.9% | ||
| Q2 25 | 20.6% | 7.7% | ||
| Q1 25 | 19.0% | 7.7% | ||
| Q4 24 | 20.0% | -3.9% | ||
| Q3 24 | 19.6% | 7.5% | ||
| Q2 24 | 19.4% | 11.5% | ||
| Q1 24 | 18.2% | -7.0% |
| Q4 25 | 1.9% | -0.8% | ||
| Q3 25 | 10.5% | -0.7% | ||
| Q2 25 | 2.0% | 7.7% | ||
| Q1 25 | -1.4% | 6.2% | ||
| Q4 24 | -6.4% | 0.1% | ||
| Q3 24 | -0.9% | 5.6% | ||
| Q2 24 | 0.4% | 8.6% | ||
| Q1 24 | -0.9% | -5.2% |
| Q4 25 | $0.07 | $-0.11 | ||
| Q3 25 | $0.33 | $-0.10 | ||
| Q2 25 | $0.06 | $1.15 | ||
| Q1 25 | $-0.04 | $0.86 | ||
| Q4 24 | $-0.23 | $0.02 | ||
| Q3 24 | $-0.03 | $0.82 | ||
| Q2 24 | $0.01 | $1.43 | ||
| Q1 24 | $-0.04 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $19.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3B | $815.2M |
| Total Assets | $5.4B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | $19.8M | ||
| Q3 25 | $147.4M | $23.7M | ||
| Q2 25 | $133.5M | $18.4M | ||
| Q1 25 | $86.1M | $8.3M | ||
| Q4 24 | $76.7M | $19.6M | ||
| Q3 24 | $67.8M | $17.3M | ||
| Q2 24 | $52.1M | $12.1M | ||
| Q1 24 | $77.0M | $20.6M |
| Q4 25 | $3.3B | $815.2M | ||
| Q3 25 | $2.7B | $818.2M | ||
| Q2 25 | $2.4B | $823.7M | ||
| Q1 25 | $2.3B | $794.4M | ||
| Q4 24 | $2.3B | $774.6M | ||
| Q3 24 | $2.2B | $766.4M | ||
| Q2 24 | $1.9B | $746.6M | ||
| Q1 24 | $2.0B | $713.2M |
| Q4 25 | $5.4B | $1.7B | ||
| Q3 25 | $4.8B | $1.7B | ||
| Q2 25 | $4.5B | $1.6B | ||
| Q1 25 | $4.5B | $1.6B | ||
| Q4 24 | $4.5B | $1.6B | ||
| Q3 24 | $4.7B | $1.5B | ||
| Q2 24 | $4.6B | $1.5B | ||
| Q1 24 | $4.7B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $63.7M |
| Free Cash FlowOCF − Capex | — | $36.1M |
| FCF MarginFCF / Revenue | — | 10.0% |
| Capex IntensityCapex / Revenue | — | 7.7% |
| Cash ConversionOCF / Net Profit | 5.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $6.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | $63.7M | ||
| Q3 25 | $107.2M | $26.6M | ||
| Q2 25 | $71.5M | $21.1M | ||
| Q1 25 | $60.6M | $11.4M | ||
| Q4 24 | $59.5M | $64.2M | ||
| Q3 24 | $63.1M | $57.3M | ||
| Q2 24 | $59.4M | $50.2M | ||
| Q1 24 | $-6.0M | $-36.2M |
| Q4 25 | — | $36.1M | ||
| Q3 25 | — | $66.0K | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | — | $-22.6M | ||
| Q4 24 | — | $29.8M | ||
| Q3 24 | — | $26.8M | ||
| Q2 24 | — | $16.7M | ||
| Q1 24 | — | $-71.6M |
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | — | -6.0% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | -21.3% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 10.5% |
| Q4 25 | 5.12× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 7.21× | 0.67× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 182.29× | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 30.02× | 1.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
